TRAIL conjugated to nanoparticles exhibits increased anti-tumor activities in glioma cells and glioma stem cells in vitro and in vivo - Wikidata - awgldk - TriplyDB

TRAIL conjugated to nanoparticles exhibits increased anti-tumor activities in glioma cells and glioma stem cells in vitro and in vivo

TRAIL conjugated to nanoparticles exhibits increased anti-tumor activities in glioma cells and glioma stem cells in vitro and in vivo

http://www.wikidata.org/entity/Q36500367

about

Onto better TRAILs for cancer treatment Nanomedicine therapeutic approaches to overcome cancer drug resistance Role of nanotechnology and gene delivery systems in TRAIL-based therapies Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma The art of attraction: applications of multifunctional magnetic nanomaterials for malignant glioma.Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside.Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model.Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner.RTVP-1 regulates glioma cell migration and invasion via interaction with N-WASP and hnRNPK.Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma Activation of autophagy flux by metformin downregulates cellular FLICE-like inhibitory protein and enhances TRAIL- induced apoptosis.TRAIL on trial: preclinical advances in cancer therapy TRAIL and microRNAs in the treatment of prostate cancer: therapeutic potential and role of nanotechnology.Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells.Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles.Death ligands and granulysin: mechanisms of tumor cell death induction and therapeutic opportunities.Inhibition of Notch1 signaling overcomes resistance to the death ligand Trail by specificity protein 1-dependent upregulation of death receptor 5.TRAIL-NP hybrids for cancer therapy: a review.Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.Implication of 4E-BP1 protein dephosphorylation and accumulation in pancreatic cancer cell death induced by combined gemcitabine and TRAIL.Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy.Pro-apoptotic effect of TRAIL-transfected endothelial progenitor cells on glioma cells.Developing TRAIL/TRAIL death receptor-based cancer therapies.

P2860

Q26768160-725082CF-CF22-4765-BB3E-088208A0F9CE Q27011692-017FB0EB-0AED-4D99-B16A-9D9440BF6B44 Q28076798-00107377-A084-48C0-B65B-E794879C6B92 Q28816972-20047BF6-2C82-40AD-B3F4-7F4213E94F35 Q30809060-389ABB85-13C0-4800-B18C-5698BBCF49DF Q31065446-77DCE862-78E8-4682-8176-C963502A987E Q34977587-237D4610-702A-4A42-B543-43D5F42E8775 Q35832224-B4452AE0-FD51-4E95-AC74-B10081E5C6FD Q35957393-56A3F502-4A26-4EC4-89FB-40E2047407BB Q36260652-062258FF-B5AA-4BAE-801D-7104A52F7758 Q36470507-03CFB105-A962-40B2-B9F2-F20636EFED5A Q37269047-49FA57FF-2A98-4481-A746-9EF711B80A3F Q37433463-38FBB360-7C57-433E-BAF6-3A0B9AB759DA Q38137746-196685F8-2F28-4611-87C2-18E006117A32 Q38322466-9E36CC9D-E376-4E05-8569-9F4365D18EF6 Q38566898-79171345-8789-4F3A-A77D-7C498E5D2EA2 Q38575137-E0BFEE8D-D73A-4957-9CAD-861BD2C1D4E8 Q38827688-4CD0BFE7-65F2-4D9A-84DC-D7DAC0E7DB49 Q39263297-7D0F08B3-ED6D-4BC7-B802-D96D36B0273E Q40511505-F8A8BCC7-AE99-45EF-9D43-F5464442B280 Q42391294-28850001-9FCF-4E52-ADDA-F9A2E3167B02 Q47300891-36C51BBF-9A7E-48CA-A490-142D90FFC90E Q47707153-231F4674-E1BB-452E-92E7-C4DC3E30ADB8 Q52653034-A15693A6-4FDC-40E9-AE5A-CD3E3728843B Q53701901-9099AE5C-DA5B-4F99-87A7-E9C1CBA5A4DA

P2860

TRAIL conjugated to nanoparticles exhibits increased anti-tumor activities in glioma cells and glioma stem cells in vitro and in vivo

http://www.wikidata.org/entity/Q36500367

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

TRAIL conjugated to nanopartic ...... tem cells in vitro and in vivo

@ast

TRAIL conjugated to nanopartic ...... tem cells in vitro and in vivo

@en

type

label

TRAIL conjugated to nanopartic ...... tem cells in vitro and in vivo

@ast

TRAIL conjugated to nanopartic ...... tem cells in vitro and in vivo

@en

prefLabel

TRAIL conjugated to nanopartic ...... tem cells in vitro and in vivo

@ast

TRAIL conjugated to nanopartic ...... tem cells in vitro and in vivo

@en

P1433

Q36500367-CA9D63CA-42A3-42DC-AB02-82DFB0FBAF89

P1476

Q36500367-2028F2F6-4E91-489E-B8C1-E4415E673D57

P2093

Q36500367-00B5234D-9C98-416C-B789-C5B8E8882A35

Q36500367-0A5A1950-6B8E-4521-9BB2-1DC118E1AA59

Q36500367-173AB1EF-0C39-410A-83ED-998BAF6B74E3

Q36500367-19C71F82-BCB6-4C15-ADCE-08A2552A21BB

Q36500367-1B53E0CB-D510-418A-B6AF-819E49AFD9E0

Q36500367-2002EA18-82F4-4A42-A50D-C4D120BC4CBF

Q36500367-49082502-3D1B-4A47-BBF6-FF71F405CB16

Q36500367-6ACA4BCD-88D6-4FD1-A4DB-0DBC4CFDA511

Q36500367-700D01FA-791D-486D-AE2F-E868EAACD797

Q36500367-8A504B62-9CE4-44E5-B1D8-E1DC6A6022FA

P2860

Q36500367-07B801E1-7176-46A4-A1B1-880F4E2215E7

Q36500367-14E10B95-2DAC-4D50-9BA4-219E816505E4

Q36500367-1C32A818-C7AC-4A88-BCEA-5AE79EB2BE0C

Q36500367-1E233FF2-558A-412F-926D-1EAB5EA661E4

Q36500367-1F718D6E-0338-44AD-A710-6EF473DD6705

Q36500367-20268151-FC66-4B2F-BF8A-1479B43B7548

Q36500367-2FF76527-9848-465E-822D-396BAEA5641A

Q36500367-35E74CA2-C331-4997-BD85-7B1D679CE73A

Q36500367-3B053FB0-D528-437B-B0F6-3984986FE10E

Q36500367-3CD2E486-2A49-41EB-81E4-FA13D0FC4896

P304

Q36500367-9FAB6C56-BAAC-4224-B2DD-5630E49305DD

P31

Q36500367-4E75999F-FD14-4D0C-BE8D-8987D005D3B1

P356

Q36500367-4F258216-6A96-4959-B68E-8DD243F6EE85

P433

Q36500367-3AB5B1D7-806E-4B55-94CA-269BDBD8ED41

P478

Q36500367-D2B3D410-8021-4FD7-88DE-A4DCEAB8A74D

P50

Q36500367-30829E1C-C1DD-4180-A56B-EDE7BA6F7F88

Q36500367-B72A2836-ED6D-43D7-8529-27C1D6C7C2C8

P577

Q36500367-42AC0669-6B91-42BC-B001-591B40B9235B

P698

Q36500367-B6959B3D-EFFF-4C85-AFC7-95E76F5E5B7E

P921

Q36500367-FC5CD2CF-3757-40AD-ACFC-42D3C6A45777

P932

Q36500367-188C1CBB-97A2-4E8D-B535-4C66852D0D20

P356

P1433

P1476

TRAIL conjugated to nanopartic ...... tem cells in vitro and in vivo

@en

P2093

Benny Perlstein

http://www.w3.org/2001/XMLSchema#string

Cathie Miller

http://www.w3.org/2001/XMLSchema#string

Felix Umansky

http://www.w3.org/2001/XMLSchema#string

Gila Kazimirsky

http://www.w3.org/2001/XMLSchema#string

Hae Kyung Lee

http://www.w3.org/2001/XMLSchema#string

Hana Okhrimenko

http://www.w3.org/2001/XMLSchema#string

Mark Rosenblum

http://www.w3.org/2001/XMLSchema#string

Nancy Lemke

http://www.w3.org/2001/XMLSchema#string

Sandra A Rempel

http://www.w3.org/2001/XMLSchema#string

Shlomit Brodie

http://www.w3.org/2001/XMLSchema#string

P2860

Roles of tyrosine phosphorylation and cleavage of protein kinase Cdelta in its protective effect against tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

An integrated genomic analysis of human glioblastoma multiforme

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Malignant astrocytic glioma: genetics, biology, and paths to treatment

Imaging and drug delivery using theranostic nanoparticles

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.

Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy.

The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma

Cilengitide induces autophagy-mediated cell death in glioma cells.

P304

29-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOS248

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23144078

http://www.w3.org/2001/XMLSchema#string

P921

P932

3534416

http://www.w3.org/2001/XMLSchema#string